Territory Manager - San Fransico, CA
Becton Dickinson
Summary
The Territory Manager is designed for experienced sales professionals who will manage and grow relationships with large-scale healthcare organizations, including integrated delivery networks (IDNs), and major hospital systems.
Job description
This role will be responsible for calling on anesthesiologists, cardiac surgeons, critical care medicine, cardiac surgeons and EP Lab. Primary products include FloTrac Sensor, ClearSight cuff, Acumen IQ cuff/sensors and ForeSight used for continuous noninvasive blood pressure monitoring and/or tissue oximetry devices utilized in outpatient surgeries. These products assist in enhanced surgical recovery, hypotension management, sepsis and shock management.
This role drives business growth within new and existing accounts by identifying opportunities and closing deals, while also analyzing performance gaps and executing short-term regional strategies to meet sales targets.
Territory will cover West Bay Territory San Jose, San Fran, and Fresno and candidate should reside in San Fran or Bay area.
Requirements
- Associate's degree in related field
- 3+ years of progressive sales experience
- Medical devices industry experience
- Exceptional communication, negotiation, and consultative selling skills
- Strong enterprise-level selling skills
Company overview
Becton, Dickinson and Company (BD) is a leading American multinational medical technology company founded in 1897 and headquartered in Franklin Lakes, New Jersey. As one of the largest global medical technology companies, BD specializes in manufacturing and selling medical devices, instrument systems, and reagents while also providing consulting and analytics services. The company operates through three main segments: BD Medical (focusing on medication delivery and management), BD Life Sciences (specializing in diagnostics and biosciences), and BD Interventional (concentrating on surgical and critical care interventions). With over 72,000 employees worldwide, BD has established a significant presence in virtually every country and serves healthcare providers, hospitals, clinics, pharmaceutical companies, and research institutions. The company is publicly traded on the New York Stock Exchange (NYSE: BDX) and is a component of the S&P 500 index. BD has a long history of innovation, including developing the first insulin injection device in 1924, the first sterile disposable medical device in 1952, and pioneering safety-engineered syringes. The company continues to advance healthcare through its commitment to improving medical discovery, diagnostics, and care delivery while addressing global health challenges.